According to experts, until the effectiveness of the drug is proven during a full cycle of clinical trials according to international standards, Russians are unlikely to trust it.
Inhale, not prick
The Mir-19 drug, as its developers say, blocks virus particles that are responsible for copying covid molecules and, accordingly, stops the spread of the virus inside the body.
Mir-19 is injected through the respiratory tract by medical nebulizers. This contributes to the “targeted delivery of the drug to the upper and lower respiratory tract,” said Musa Khaitov, director of the SSC “Institute of Immunology” of the FMBA.
It is allowed for use by people aged 18 to 65 years. It is contraindicated in pregnant and lactating women, patients with severe coronavirus infection and taking glucocorticosteroids, according to the instructions for the drug.